Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Return on Sales: 2014-2020

Historic Return on Sales for Larimar Therapeutics (LRMR) over the last 5 years, with Mar 2020 value amounting to 22.91%.

  • Larimar Therapeutics' Return on Sales fell 718.00% to 22.91% in Q1 2020 from the same period last year, while for Mar 2020 it was 22.91%, marking a year-over-year decrease of 718.00%. This contributed to the annual value of 25.73% for FY2019, which is 648.00% down from last year.
  • According to the latest figures from Q1 2020, Larimar Therapeutics' Return on Sales is 22.91%, which was down 10.94% from 25.73% recorded in Q4 2019.
  • In the past 5 years, Larimar Therapeutics' Return on Sales ranged from a high of 316.17% in Q4 2017 and a low of 22.91% during Q1 2020.
  • Over the past 3 years, Larimar Therapeutics' median Return on Sales value was 30.09% (recorded in 2019), while the average stood at 40.95%.
  • Its Return on Sales has fluctuated over the past 5 years, first soared by 20,679bps in 2017, then crashed by 28,396bps in 2018.
  • Over the past 5 years, Larimar Therapeutics' Return on Sales (Quarterly) stood at 109.38% in 2016, then surged by 20,679bps to 316.17% in 2017, then tumbled by 28,396bps to 32.21% in 2018, then plummeted by 648bps to 25.73% in 2019, then plummeted by 718bps to 22.91% in 2020.
  • Its last three reported values are 22.91% in Q1 2020, 25.73% for Q4 2019, and 27.66% during Q3 2019.